CF PharmTech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	414.9	81.94	70.61	74.84	183.29
Short-Term Investments	2.99	6.1	5.5	5.56	-
Trading Asset Securities	238.34	266.06	330.85	236.39	201.44
Cash & Short-Term Investments	656.22	354.1	406.96	316.79	384.73
Cash Growth	85.32%	-12.99%	28.46%	-17.66%	-38.19%
Accounts Receivable	159.37	27.13	2.87	8.94	1.09
Other Receivables	5.57	1.38	1.9	-	0.02
Receivables	164.94	28.51	4.77	8.94	1.6
Inventory	36.7	47.18	36.1	28.29	19.85
Restricted Cash	7.63	5.12	19.17	114.94	-
Other Current Assets	24.68	27.31	28.05	15.31	54.2
Total Current Assets	890.16	462.22	495.04	484.26	460.37
Property, Plant & Equipment	575.23	562.3	430.45	328.46	276.13
Long-Term Investments	3.7	1.83	1.9	-	105.76
Other Intangible Assets	154.89	33.22	44.92	52.15	32.58
Long-Term Deferred Tax Assets	110.77	94.87	92.97	83.69	62.47
Long-Term Deferred Charges	-	88.73	50.02	23.37	48.58
Other Long-Term Assets	41.53	15.81	19.85	43.27	6.92
Total Assets	1,776	1,259	1,135	1,015	992.97
Accounts Payable	21.38	20.59	27.21	13.12	13.83
Accrued Expenses	42.22	116.95	72.69	57.75	22.98
Current Portion of Long-Term Debt	44.52	18.47	0.82	-	-
Current Portion of Leases	1.56	2.43	1.9	1.26	-
Current Income Taxes Payable	6.45	4.12	2.41	5.83	0.46
Current Unearned Revenue	10.82	6.46	35.35	21.8	11.61
Other Current Liabilities	67.01	76.59	31.09	37.44	24.81
Total Current Liabilities	193.96	245.61	171.47	137.19	73.69
Long-Term Debt	97.79	55.35	19.2	-	-
Long-Term Leases	1.69	2.85	-	0.24	1.44
Long-Term Unearned Revenue	12.49	15.94	34.46	15.86	1.28
Other Long-Term Liabilities	2	-	-	-	21.8
Total Liabilities	307.93	319.74	225.12	153.29	98.21
Common Stock	411.98	370.78	370.78	370.78	370.78
Additional Paid-In Capital	-	-	-	-	1,333
Retained Earnings	-	-804.9	-825.99	-857.71	-808.31
Treasury Stock	-2.09	-	-	-	-
Comprehensive Income & Other	1,058	1,373	1,365	1,349	-0.25
Shareholders' Equity	1,468	939.28	910.02	861.93	894.76
Total Liabilities & Equity	1,776	1,259	1,135	1,015	992.97
Total Debt	145.56	79.1	21.91	1.5	1.44
Net Cash (Debt)	510.66	275.01	385.05	315.28	383.29
Net Cash Growth	85.69%	-28.58%	22.13%	-17.74%	-38.42%
Net Cash Per Share	1.35	0.74	1.04	0.85	-
Filing Date Shares Outstanding	411.98	370.78	370.78	370.78	-
Total Common Shares Outstanding	411.98	370.78	370.78	370.78	-
Working Capital	696.2	216.61	323.58	347.08	386.68
Book Value Per Share	3.56	2.53	2.45	2.32	-
Tangible Book Value	1,313	906.06	865.11	809.78	862.17
Tangible Book Value Per Share	3.19	2.44	2.33	2.18	-
Buildings	-	236.47	167.34	154.04	106.64
Machinery	-	287.25	249.45	175.92	151.25
Construction In Progress	-	180.94	117.61	71.29	90.02
Leasehold Improvements	-	17.35	14.23	7.68	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.